Keck Medicine of USC Koreatown — Los Angeles, California

Keck Medicine of USC Koreatown is a clinical research site located in Los Angeles, California, United States 90020.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Keck Medicine of USC Koreatown has participated in 39 clinical trials with 38 currently active.

Therapeutic areas: Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8.

Sponsors: SWOG Cancer Research Network, National Cancer Institute (NCI), NRG Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Keck Medicine of USC Koreatown?

Keck Medicine of USC Koreatown has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Keck Medicine of USC Koreatown conducted?

Keck Medicine of USC Koreatown has 39 clinical trials on record, with 38 currently active. Their work covers Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8.

Is Keck Medicine of USC Koreatown accredited by Crixeo Health?

Yes — Keck Medicine of USC Koreatown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Keck Medicine of USC Koreatown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.